Australia Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Diabetes Products in Australia and the Market is Segmented Into Management Devices (insulin Pumps (insulin Pump Devices, Insulin Pump Reservoir, And Infusion Set), Insulin Syringes, Insulin Cartridges in Reusable Pens, Disposable Insulin Pens, And Jet Injectors), And Monitoring Devices (self-Monitoring Blood Glucose (glucometer Devices, Blood Glucose Test Strips, And Lancets) and Continuous Glucose Monitoring (sensors and Durables)). The Market Provides the Value (in USD) for the Above-Mentioned Segments.

Australia Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Australia Diabetes Care Devices Market Size

View Global Report
Australia Diabetes Care Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 721.44 Million
Market Size (2030) USD 814.65 Million
CAGR (2025 - 2030) 2.46 %

Major Players

Australia Diabetes Care Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Australia Diabetes Care Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Australia Diabetes Care Devices Market Analysis

The Australia Diabetes Care Devices Market size is estimated at USD 721.44 million in 2025, and is expected to reach USD 814.65 million by 2030, at a CAGR of 2.46% during the forecast period (2025-2030).

According to Australian National Health Survey, one in twenty (5.3%) people had diabetes. Type 2 diabetes was the most common type of diabetes (85.5%), followed by Type 1 diabetes (11.0%) and type not known by the person reporting (4.1%). The main diagnosis for diabetes patients is imbalances in blood glucose levels, which are not in compliance with the standard blood glucose levels. The general lab diagnostic tests can only help to diagnose the disease by physicians. Patients with more fluctuations in glucose levels need to get it checked every day. Patients administering insulin need to check their blood glucose levels frequently, adjust the doses of insulin, or change the medication, if necessary.

The rate of newly diagnosed Type 1 and Type 2 diabetes cases is seen to increase, mainly due to obesity, unhealthy diet, and physical inactivity. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure in developed countries are indications of the increasing usage of diabetic care products. 

Moreover, the increasing adoption of insulin delivery devices and the rising prevalence of diabetes are driving the market growth. Leading manufacturers are focusing on technological innovations and the development of advanced products to gain a substantial share of the market.

The Australian National Diabetes Strategy is designed in response to diabetes and informs how existing limited healthcare resources can be better coordinated and targeted across all levels of Government. This Strategy identifies the most effective and appropriate interventions to reduce the diabetes impact in the community and leads the way internationally in diabetes prevention, management, and research.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

Australia Diabetes Care Devices Industry Overview

The Australian Diabetes Care Devices Market is semi consolidated, with few significant and generic players. Manufacturers drive constant innovations to compete in the market. The major players, such as Abbott and Medtronic, underwent many mergers, acquisitions, and partnerships to establish market dominance while adhering to organic growth strategies. It is evident from the R&D spending of these companies.

Australia Diabetes Care Devices Market Leaders

  1. Abbott Diabetes Care

  2. Novo Nordisk A/S

  3. Medtronic PLC

  4. Dexcom Inc.

  5. Roche Diabetes Care

  6. *Disclaimer: Major Players sorted in no particular order
Australia Diabetes Care Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Australia Diabetes Care Devices Market News

  • November 2023: The Australian government has granted approval for individuals to obtain prescriptions for continuous glucose monitoring (CGM) devices from various healthcare professionals, including General Practitioners (GPs), diabetes educators, diabetes clinics, Registered Nurses (RNs), and specialists.
  • November 2022: Eli Lilly and Company announced that it would roll out its first connected platform, the Tempo Personalized Diabetes Management Platform. The technology aims to help adults with type 1 or 2 diabetes and clinicians make informed, data-backed decisions to manage treatment with Lilly insulins. The platform consists of three key components - the Tempo Smart Button, a compatible app; TempoSmart and a prefilled insulin pen, Tempo Pen. They work together to deliver personalized guidance for adults with diabetes.

Australia Diabetes Care Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Management Devices
    • 5.1.1 Insulin Pump
    • 5.1.1.1 Insulin Pump Device
    • 5.1.1.2 Insulin Pump Reservoir
    • 5.1.1.3 Infusion Set
    • 5.1.2 Insulin Syringes
    • 5.1.3 Cartridges in Reusable Pens
    • 5.1.4 Insulin Disposable Pens
    • 5.1.5 Jet Injectors
  • 5.2 Monitoring Devices
    • 5.2.1 Self-monitoring Blood Glucose
    • 5.2.1.1 Glucometer Devices
    • 5.2.1.2 Blood Glucose Test Strips
    • 5.2.1.3 Lancets
    • 5.2.2 Continuous Glucose Monitoring
    • 5.2.2.1 Sensors
    • 5.2.2.2 Durables

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Novo Nordisk A/S
    • 7.1.2 Sanofi Aventis
    • 7.1.3 Eli Lilly
    • 7.1.4 Roche Diabetes Care
    • 7.1.5 Abbott Diabetes Care
    • 7.1.6 LifeScan Inc.
    • 7.1.7 ARKRAY Inc.
    • 7.1.8 Ascensia Diabetes Care
    • 7.1.9 AgaMatrix Inc.
    • 7.1.10 Dexcom Inc.
    • 7.1.11 Insulet Corporation
    • 7.1.12 Medtronic
    • 7.1.13 Ypsomed Holding AG
  • *List Not Exhaustive
  • 7.2 Company Share Analysis
    • 7.2.1 Self-monitoring Blood Glucose Devices
    • 7.2.1.1 Abbott Diabetes Care
    • 7.2.1.2 LifeScan Inc.
    • 7.2.1.3 Others
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.2.1 Dexcom Inc.
    • 7.2.2.2 Medtronic PLC
    • 7.2.2.3 Others
    • 7.2.3 Insulin Devices
    • 7.2.3.1 Insulet Corporation
    • 7.2.3.2 Novo Nordisk A/S
    • 7.2.3.3 Others

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Australia Diabetes Care Devices Industry Segmentation

Diabetes care devices are the hardware, equipment, and software used by diabetes patients to regulate blood glucose levels, prevent diabetes complications, lessen the burden of diabetes, and enhance the quality of life. The australia diabetes care devices market is segmented into monitoring devices, management devices and geography. The report offers the value (in usd) and volume (in units) for the above segments.

Management Devices Insulin Pump Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes
Cartridges in Reusable Pens
Insulin Disposable Pens
Jet Injectors
Monitoring Devices Self-monitoring Blood Glucose Glucometer Devices
Blood Glucose Test Strips
Lancets
Continuous Glucose Monitoring Sensors
Durables
Need A Different Region or Segment?
Customize Now

Australia Diabetes Care Devices Market Research FAQs

How big is the Australia Diabetes Care Devices Market?

The Australia Diabetes Care Devices Market size is expected to reach USD 721.44 million in 2025 and grow at a CAGR of 2.46% to reach USD 814.65 million by 2030.

What is the current Australia Diabetes Care Devices Market size?

In 2025, the Australia Diabetes Care Devices Market size is expected to reach USD 721.44 million.

Who are the key players in Australia Diabetes Care Devices Market?

Abbott Diabetes Care, Novo Nordisk A/S, Medtronic PLC, Dexcom Inc. and Roche Diabetes Care are the major companies operating in the Australia Diabetes Care Devices Market.

What years does this Australia Diabetes Care Devices Market cover, and what was the market size in 2024?

In 2024, the Australia Diabetes Care Devices Market size was estimated at USD 703.69 million. The report covers the Australia Diabetes Care Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Australia Diabetes Care Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Australia Diabetes Care Devices Industry Report

Statistics for the 2025 Australia Diabetes Care Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Australia Diabetes Care Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.